Thank you for attending our Cancer52 Manifesto for rare and less common cancers today #C52Manifesto

Delighted to head to Westminster today to support Cancer52 manifesto for rare cancers. We are passionate about supporting patients with rare cancers and improving outcomes. We hope many of them will be involved with the DETERMINE trial running across the UK ECMC Network Cancer Research UK

Well done to Cancer52 for the successful launch of their Rare & Less Common Cancers manifesto, 'The Other Half' at UK House of Commons, Westminster, today. Fantastic networking opportunity for #AMMF , too!
#rarecancer #cholangiocarcinoma #livertwitter

doi.org/10.3389/fonc.2…
Intraductal magnetic resonance imaging of cholangiocarcinoma - a practical possibility

Great work from Imperial and Khon Kaen University teams, and funded by AMMF, the Cholangiocarcinoma Charity

AMMF มหาวิทยาลัยขอนแก่น Imperial College London

Still time to register and join us in Madrid for the ILCA STW on #livercancer #HCC #CCA . New therapeutic options, multidisciplinary approach, clinical case discussion!

Well done Alicia Conway and CRUK Manchester Institute in collaboration with The Christie NHS and #MCRC biobank & #HPB clinicians in enabling study on blood-based biomarker diagnosis/early detection in #BTCs AMMF Manchester Cancer Research Centre

We are delighted to see this exciting #AMMF -supported work published. A great collaborative effort between the teams at #ImperialCollege London and Khon Kaen University (Khon Kaen University), Thailand!
lnkd.in/e_2ZCWqy
#cholangiocarcinoma #Livertwitter

📣 ¡Únete a nuestro Webinar sobre el ABC del Cáncer de Vías Biliares con ATUVIBI! La Dra. Angela Lamarca, Dra. Cristna Huete y Matilde García-Oliva compartirán información crucial sobre esta enfermedad.

🗓️ 10 de abril a las 18:00
Regístrate aquí: forms.wix.com/f/718174738757…

Great news for patients diagnosed with Biliary Malignancies and HCC in Spain - Angela Lamarca
Grupo Español de Tratamiento de Tumores Digestivos SEOM ENS-CCA

#Cancer #CisGem #Chemotherapy #HCC #OncoDaily #Oncology

oncodaily.com/42503.html

Congratulation Dr Laura Randle (she/her) and team!! 'The importance of preclinical models in #cholangiocarcinoma ...'

Register today for AMMF’s Hybrid 2024 European Cholangiocarcinoma Conference! Join us to learn about the challenges faced and advances made in our understanding of CCA: ammf.org.uk/ammf-conferenc…

#cholangiocarcinoma #AMMF2024 #LiverTwitter

Dr Sivakumar, associate professor in oncology ⁦⁦⁦Uni of Birmingham⁩ “There is an epidemic currently of young people getting cancer. It is unknown the cause of this, but we are seeing more patients getting abdominal cancers.” #LateDiagnosis 🦓🦓 🦓
telegraph.co.uk/news/2024/03/2…

All at #AMMF send sincere good wishes to The Princess of Wales for a speedy recovery & return to full health. With generosity of spirit she included thoughts for all with cancer in her courageous words – we thank Her Royal Highness for that.
The Prince and Princess of Wales #cholangiocarcinoma

At #AMMF ’s Hybrid 2024 European #Cholangiocarcinoma Conference, we will host a faculty of global speakers to learn about the challenges faced and advances made in our understanding of CCA.

Sign up today: ammf.org.uk/ammf-conferenc…

#AMMF 2024 #cholangiocarcinoma

Apologies for the lengthy message, but this is really important to me.
We need to join forces to make targeted therapies a global success story in cholangiocarcinoma
🧐Here's what we need:
👉Cutting-edge & validated genetic testing
👉Better understanding of resistance mechanisms…

We are thrilled to host a faculty of CCA experts who will discuss challenges in #cholangiocarcinoma & advances made in the fight against this devastating cancer.

Register now: ammf.org.uk/ammf-conferenc…

#AMMF2024 #LiverTwitter @cholangiocarcinoma #BileDuctCancer

Many thanks to JHEP Reports for posting this - one of the papers resulting from #AMMF 's #cholangiocarcinoma data project, 3 papers now published.
#livertwitter #bileductcancer

Reports today show cancer deaths are falling BUT #AMMF ’s published data show #cholangiocarcinoma increasing markedly with parallel mortality. Our #RethinkLiverCancer Campaign calls for an improved future for all with CCA: ammf.org.uk/rethink-liver-…

thetimes.co.uk/article/middle…

🟪NEW Article in press❕

Recommendations maximising the clinical value of tissue in the management of patients with intrahepatic cholangiocarcinoma

🔓 #OpenAccess at 👉 jhep-reports.eu/article/S2589-…

#LiverTwitter